The discovery of α-Klotho and FGF23 unveiled new insight into calcium and phosphate homeostasis

Cellular and Molecular Life Sciences

Volumn 65, Issue 20, 2008, Pages 3218-3230

  Nabeshima, Y ^a,b  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Klotho; Calcium homeostasis; Calcium sensing receptor; FGF23; K+ ATPase; Na+; Parathyroid hormone; Phosphate homeostasis; Vitamin D

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BETA GLUCURONIDASE; FIBROBLAST GROWTH FACTOR 23; KLOTHO PROTEIN; PARATHYROID HORMONE; PROTEIN ALPHA KLOTHO; UNCLASSIFIED DRUG;

CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL MEMBRANE; COMPLEX FORMATION; ENZYME ACTIVITY; EXTRACELLULAR CALCIUM; GENE MUTATION; HORMONE RELEASE; MEMBRANE PERMEABILITY; NONHUMAN; PHENOTYPE; PHOSPHATE METABOLISM; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; VITAMIN D METABOLISM;

ANIMALS; CALCIUM; FIBROBLAST GROWTH FACTORS; GLUCURONIDASE; HOMEOSTASIS; HUMANS; PHOSPHATES; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 53849118425     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-8177-0     Document Type: Review

References (83)

1. 2+ and other ions as extracellular (first) messengers. Physiol. Rev. 71, 371-411.
2. Borle A. B. (1981) Control, modulation, and regulation of cell calcium. Rev. Physiol. Biochem. Pharmacol. 90, 13-153.
3. Parfitt A. M. and Kleerekoper M. (1980) The divalent ion homeostatic system: Physiology and metabolism of calcium, phosphorus, magnesium, and bone. In: Clinical Disorders of Fluid and Electrolyte Metabolism, 3rd edn., pp. 269-398, Maxwell M. H. and Kleeman C. R. (eds.), McGraw-Hill, New York.
4. 2+ sensing receptor from bovine parathyroid. Nature 366, 575-580.
5. Stewart A. F. and Broadus A. E. (1987) Mineral metabolism. In: Endocrinology and Metabolism, 2nd edn., pp. 1317-1453, Felig, P., Baxter, J. D., Broadus, A. F. and Frohman, L. A. (eds.), McGraw-Hill, New York.
6. Aurbach G. D., Marx S. J. and Spiegel A. M. (1985) Parathyroid hormone, calcitonin, and the calciferols. In: Textbook of Endocrinology, 7th edn., pp. 1137-1217, Wilson J. D. and Foster D. W. (eds.), Saunders, Philadelphia.
7. Brown E. M. (1983) Regulation of the synthesis, secretion and actions of parathyroid hormone. In: Contemporary Issues in Nephrology. Divalent Cation Homeostasis, vol. 11, pp. 151-188, Brenner B. M. and Stein J. H. (eds.), Churchhill-Livingstone, New York.
8. Brown E. M., Chen C. J., Leboff M. S., Kifor O. and El-Hajj G. (1989) Mechanisms underlying the inverse control of parathyroid hormone secretion by calcium. In: Secretion and Its Control, pp. 252-268, Oxford G. and Armstrong C. M. (eds.), Rockfeller University Press, New York.
9. Austin L. A. and Heath H. III (1981) Calcitonin. Physiology and pathophysiology. N. Engl. J. Med. 304, 269-278.
10. Bilezikian JP, Marcus R and Levine MA (2003) Section II: Physiological aspects of the parathyroid. In: The Parathyroids: Basic and Clinical Concepts, 2nd edn., pp. 167-291, Bilezikian J. P., Marcus R. and Levine M. A. (eds.), Academic Press, New York.
11. Wilson J. D., Foster D. W., Kronenberg H. M. and Larsen P. R. (2003) Hormones and disorders of mineral metabolism. In: Williams Textbook of Endocrinology, pp. 1303-1371, Bringhurst F. R., Demay M. B. and Kronenberg H. M. (eds.), Saunders, Philadelphia.
12. Blum J. W., Trescel U., Born W., Tobler P. H., Taylor C. M., Binswanger U. and Fischer J. A. (1983) Rapidity of plasma 1,25-dihydroxyvitamin D responses to hypo- and hypercalcemia in steers. Endocrinology 113, 523-526.
13. Brown E. M., Leombruno R., Thatcher J and Burrowes M. (1985) The acute secretory response to alterations in the extracellular calcium concentration and dopamine in perifused bovine parathyroid cells. Endocrinology 116, 1123-1132.
14. Wallfelt C., Lindh E., Larsson R., Johansson H., Rastad J., Akerstrom G. and Gylfe E. (1988) Kinetic evidence for cytoplasmic calcium as an inhibitory messenger in parathyroid hormone release. Biochim. Biophys. Acta 969, 257-262.
15. Raisz L. G. (1965) Bone resorption in tissue culture: Factors influencing the response to parathyroid hormone. J. Clin. Invest. 44, 103-110.
16. Raisz L. G. and Kream B. E. (1983) Regulation of bone formation. N. Engl. J. Med. 309, 35-39.
17. Fraser D. R. and Kodicek E. (1973) Regulation of 25- hydroxycholecalciferol- hydroxylase activity in kidney by parathyroid hormone. Nat. New Biol. 241, 163-166.
18. 3. Application to hypervitaminosis D. J. Clin. Invest. 58, 61-70.
19. 3 by calcium and phosphate in the rat. Science 190, 578-590.
20. Brumbaugh P. F., Hughes M. R. and Haussler M. R. (1975) Cytoplasmic and nuclear binding components for 1,25-dihydroxyvitamin D3 in chick parathyroid glands. Proc. Natl. Acad. Sci. USA 72, 4871-4875.
21. Marx S. J. Liberman U. A. and Eil C. A. (1983) Calciferols: Actions and deficiencies in actions. Vitam. Horm. 40, 235-308.
22. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsuki T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R and Nabeshima Y (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45-51.
23. Henrissat B and Davies G (1997) Structural and sequence-based classification of glycoside hydrolases. Curr. Opin. Struct. Biol. 7, 637-644.
24. Imura A, Iwano A, Kita N, Thoyama O, Fujimori T and Nabeshima Y (2004) Secreted Klotho protein in sera and CSF: Implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett. 565, 143-147.
25. Chang Q., Hoefs S., van der Kemp A. W., Topala C. N., Bindels R. J. and Hoenderop J. G. (2005) The β-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 310, 490-493.
26. Takeshita K., Fujimori T., Kurotaki Y., Honjo H., Tsujikawa H., Yasui K., Lee J. K., Kamiya K., Kitaichi K., Yamamoto K., Ito M., Kondo T., Iino S., Inden Y., Hirai M., Murohara T., Kodama I. and Nabeshima Y. (2004) Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression. Circulation 109, 1776-1782.
27. Brown E. M. and MacLead R. J. (2001) Extracellular calcium sensing and extra cellular calcium signaling. Physiol. Rev. 81. 239-297.
28. 2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5. J. Clin. Invest. 112, 1906-1914.
29. Strange K. (1992) Regulation of solute and water balance and cell volume in the central nervous system. J. Am. Soc. Nephrol. 3, 12-27.
30. Somjen G. G. (2002) Ion regulation in the brain: Implications for pathophysiology. Neuroscientist 8, 254-267.
31. Imura A., Tsuji Y., Murata M., Maeda R., Kubota K., Iwano A., Obuse C., Togashi K., Tominaga M., Kita N., Tomiyama K., Iijima J., Nabeshima Y., Fujioka M., Asato R., Tanaka S., Kojima K., Ito J., Nozaki K., Hashimoto N., Ito T., Nishio T., Uchiyama T., Fujimori T. and Nabeshima Y. (2007) α-Klotho as a regulator of calcium homeostasis. Science 316, 1615-1618.
32. The ADHR Consortium (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat. Genet. 26, 345-348.
33. Yamashita T., Yoshioka M. and Itoh N. (2000) Identification of a novel fibroblast growth factor, FGF23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem. Biophys. Res. Commun. 277, 494-498.
34. Itoh N. and Ornitz D. M. (2004) Evolution of the Fgf and Fgfr gene families. Trends Genet. 20, 563-569.
35. White K. E., Carn G., Lorenz-Depiereux B., Benet-Pages A., Strom T. M. and Econs M. G. (2001) Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF23. Kidney Int. 60, 2079-2086.
36. Shimada T., Muto T., Urakawa I., Yoneya T., Yamazaki Y., Okawa K., Takeuchi Y., Fujita T., Fukumoto S. and Yamashita T. (2002) Mutant FGF23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology 143, 3179-3182.
37. Shimada T., Mizutani S., Muto T., Yoneda T., Hino R., Takeda S., Takeuchi Y., Fujita T., Fukumoto S. and Yamashita T. (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc. Natl. Acad. Sci. USA 98, 6500-6505.
38. Bai XY, Miao D, Goltzman D. and Karaplis A, C. (2003) The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency. J. Biol. Chem. 278, 9843-9849.
39. Shimada T., Urakawa I., Yamazaki Y., Hasegawa H., Hino R., Yoneya T., Takeuchi Y., Fujita T., Fukumoto S. and Yamashita T. (2004) FGF23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. Biochem. Biophys. Res. Commun. 314, 409-414.
40. Larsson T., Marsell R., Schipani E., Ohlsson C., Ljunggren O., Tenenhouse H. S., Jüppner H. and Jonsson K. B. (2004) Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology 145, 87-94.
41. Bai X., Miao D., Li J., Goltzman D. and Karaplis A. C. (2004) Transgenic mice overexpressing human fibroblast growth factor 23(R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. Endocrinology 145, 5269-5279.
42. Shimada T., Kakitani M., Yamazaki Y., Hasegawa H., Takeuchi Y., Fujita T., Fukumoto S., Tomizuka K. and Yamashita T. (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. 113, 561-568.
43. Sitara D., Razzaque M. S., Hesse M., Yoganathan S., Taguchi T., Erben R. G., Jüppner H. and Lanske B. (2004) Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol. 23, 421-432.
44. Shimada T., Hasegawa H., Yamazaki Y., Muto T., Hino R., Takeuchi Y., Fujita T., Nakahara K., Fukumoto S. and Yamashita T. (2004) FGF23 is a potent regulator of the vitamin D metabolism and phosphate homeostasis. J. Bone Miner. Res. 19, 429-435.
45. Segawa H., Kawakami E., Kaneko I., Kuwahata M., Ito M., Kusano K., Saito H., Fukushima N. and Miyamoto K. (2003) Effect of hydrolysis-resistant FGF23-R179Q on dietary phosphate regulation of the renal type-II Na/Pi transporter. Pflugers Arch. 446, 585-592.
46. Tsujikawa H., Kurotaki Y., Fujimori T., Fukuda K. and Nabeshima Y. (2003) Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol. Endocrinol. 17, 2393-2403.
47. Razzaque M. S. and Lanske B. (2006) Hypervitaminosis D and premature aging: Lessons learned from Fgf23 and Klotho mutant mice. Trends Mol. Med. 12, 298-305.
48. Razzaque M. S., Sutara D., Taguchi T., St-Arnaud R. and Lanske B. (2006) Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J. 20, 720-722.
49. Nabeshima Y. (2006) Toward a better understanding of Klotho. Sci. Aging Knowledge Environ 8, pe11.
50. Urakawa I., Yamazaki Y., Shimada T., Iijima K., Hasegawa H., Okawa K., Fujita T., Fukumoto S. and Yamashita T. (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444, 770-774.
51. Lanske B. and Razzaque M. S. (2007) Mineral metabolism and aging: The fibroblast growth factor 23 enigma. Curr. Opin. Nephrol. Hypertens. 16, 311-318.
52. Lanske B. and Razzaque M. S. (2007) Premature aging in klotho mutant mice: Cause or consequence? Ageing Res. Rev. 6, 73-79.
53. Kato K, Jeanneau C, Tarp MA, Benet-Pagès A, Lorenz-Depiereux B, Bennett EP, Mandel U, Strom TM and Clausen H. (2006) Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J. Biol. Chem. 281, 18370-18377.
54. Ichikawa S., Imel E. A., Kreiter M. L., Xijie Yu, Donald S., Mackenzie B. S., Sorenson A. H., Goetz R., Mohammadi M., White K. E. and Econs M. J. (2007) A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J. Clin. Invest. 117, 2684-269.
55. Brownstein C. A., Adler F. , Nelson-Williams C., Iijima J. , Li P. , Imura A., Nabeshima Y., Reyes-Mugica M. , Carpenter T. O. and Lifton R. P. (2008) A translocation causing increased α-Klotho level results in hypophosphatemic rickets and hyperparathyroidism. Proc. Natl. Acad. Sci. USA 105, 3455-3460.
56. +-pump. Methods Enzymol. 156, 1-25.
57. Nabeshima Y. and Imura H. (2007) α-Klotho: A regulator that integrates calcium homeostasis. Am. J. Nephrol. 28, 455-464.
58. +-ATPase. J. Bioenerg. Biomembr. 24, 249-261.
59. +-ATPase. Annu. Rev. Biochem. 71, 511-535.
60. 2+ transport. Biochem. J. 406, 365-382.
61. Blaustein M. P. and Lederer W. J. (1999) Sodium/calcium exchange: Its physiological implications. Physiol. Rev. 79, 763-854.
62. Lassiter W. C., Gottschalk C. W. and Mylle M. (1963) Micropuncture study of renal tubular reabsorption of calcium in normal rodents. Am. J. Physiol. 204, 771-775.
63. Rocha A. S., Magaldi J. B. and Kokko J. P. (1977) Calcium and phosphate transport in isolated segments of rabbit Henle's loop. J. Clin. Invest. 59, 975-983.
64. Suki W. N. (1979) Calcium transport in the nephron. Am. J. Physiol. 237, F1-F6.
65. Kinne-Saffran E. and Kinne R. (1974) Localization of a calcium stimulated ATPase in the basal-lateral plasma membranes of the proximal tubule of rat kidney cortex. J. Membr. Biol. 17, 263-274.
66. 2+ reabsorption in the proximal tubule of the rat kidney. Pfugers Arch. 364, 223-228.
67. Shareghi G. R. and Stoner L. C. (1978) Calcium transport across segments of the rabbit distal nephron in vitro. Am. J. Physiol. 235, F367-F375.
68. Quamme G. A. (1980) Effect of calcitonin on calcium and magnesium transport in rat nephron. Am. J. Physiol. 238, E573-E578.
69. Quamme G. A. (1982) Effect of hypercalcemia on renal tubular handling of calcium and magnesium. Can. J. Physiol. Pharmacol. 60, 1275-1280.
70. Sutton R. A., Wong N. L., Quamme G. A. and Dirks J. H. (1983) Renal tubular calcium transport: Effects of changes in filtered calcium load. Am. J. Physiol. 245, F515-F520.
71. Ho C., Conner D. A., Pollack M. R., Ladd D. J., Kifor O., Warren H. B., Brown E. M., Seidman J. G. and Seidman C. E. (1995) A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat. Genet. 11, 389-394.
72. Tsuruoka S., Nishiki K., Ioka T., Ando H., Saito Y., Kurabayashi M., Nagai R. and Fujimura A. (2006) Defect in parathyroid-hormone-induced luminal calcium absorption in connecting tubules of Klotho mice. Nephrol. Dial. Transplant. 21, 2762-2767.
73. Brown E. M., Watson E. J., Thatcher J. G., Koletsky R., Dawson-Hughes B. F., Posillico J. T. and Shoback D. M. (1987) Ouabain and low extracellular potassium inhibit PTH secretion from bovine parathyroid cells by a mechanism that does not involve increases in the cytosolic calcium concentration. Metabolism 36, 36-42.
74. Tohyama O., Imura A., Iwano A., Freund J. N., Henrissat B., Fujimori T. and Nabeshima Y. (2004) Klotho is a novel β-glucuronidase capable of hydrolyzing steroid β-glucuronides. J Biol. Chem. 273, 9777-9784.
75. Beck L., Karaplis A. C., Amizuka N., Hewson A. S., Ozawa H. and Tenenhouse H. S. (1998) Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc. Natl. Acad. Sci. USA 95, 5372-5377.
76. Tenenhouse H. (2005) Regulation of phosphorus homeostasis by the type IIa Na/phosphate cotransporter. Annu. Rev. Nutr. 25:197-214.
77. Forster I. C., Hernando N., Biber J. and Murer H. (2006) Proximal tubular handling of phosphate: A molecular perspective. Kidney Int. 70, 1548-1559.
78. Pfister M. F., Ruf I., Stange G., Ziegler U., Lederer E., Biber J. and Murer H. (1998) Parathyroid hormone leads to the lysosomal degradation of the renal type II Na/Pi cotransporter. Proc. Natl. Acad. Sci. USA. 95, 1909-1914.
79. Kilav R., Silver J. and Naveh-Many T. (2001) A conserved cis-acting element in the parathyroid hormone 3′-untranslated region is sufficient for regulation of RNA stability by calcium and phosphate. J. Biol. Chem. 276, 8727-8733.
80. Moallem E., Kilav R., Silver J. and Naveh-Many T. (1998) RNA-protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate. J. Biol. Chem. 273, 5253-5259.
81. Bell O., Silver J. and Naveh-Many T. (2005) Identification and characterization of cis-acting elements in the human and bovine PTH mRNA 3′-untranslated region. J. Bone Miner. Res. 20, 858-866.
82. Silver J., Kilav R., Sela-Brown A. and Naveh-Many T. (2000) Molecular mechanisms of secondary hyperparathyroidism. Pediatr. Nephrol. 14, 626-628.
83. Schoeber J. P. H., Hoenderop J. G. J. and Bindels R. J. M. (2007) Concerted action of associated proteins in the regulation of TRPV5 and TRPV6. Biochem. Soc. Trans. 35, 115-119.